Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] gained 12.13% on the last trading session, reaching $0.98 price per share at the time.
Biodexa Pharmaceuticals Plc ADR represents 0.67 million in outstanding shares, while the company has a total market value of $0.66 million with the latest information. BDRX stock price has been found in the range of $0.825 to $1.33.
If compared to the average trading volume of 2.24M shares, BDRX reached a trading volume of 20997722 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Biodexa Pharmaceuticals Plc ADR [BDRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BDRX shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BDRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Biodexa Pharmaceuticals Plc ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 08, 2024.
The Price to Book ratio for the last quarter was 2.20, with the Price to Cash per share for the same quarter was set at 3.12.
Trading performance analysis for BDRX stock
Biodexa Pharmaceuticals Plc ADR [BDRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.23. With this latest performance, BDRX shares dropped by -13.27% in over the last four-week period, additionally sinking by -77.05% over the last 6 months – not to mention a drop of -75.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BDRX stock in for the last two-week period is set at 50.26, with the RSI for the last a single of trading hit 0.1174, and the three-weeks RSI is set at 0.1230 for Biodexa Pharmaceuticals Plc ADR [BDRX]. The present Moving Average for the last 50 days of trading for this stock 1.1084, while it was recorded at 0.8983 for the last single week of trading, and 3.3368 for the last 200 days.
Biodexa Pharmaceuticals Plc ADR [BDRX]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -45.75%, with Return on Assets sitting at -45.75%.
An analysis of Institutional ownership at Biodexa Pharmaceuticals Plc ADR [BDRX]
There are presently around $7.70%, or 7.79% of BDRX stock, in the hands of institutional investors.
